Show simple item record

dc.contributor.authorRagan, E.J.
dc.contributor.authorGill, C.J.
dc.contributor.authorBanos, M.
dc.contributor.authorBouton, T.C.
dc.contributor.authorRooney, J.
dc.contributor.authorHorsburgh, C.R.
dc.contributor.authorWarren, R.M.
dc.contributor.authorMyers-Franchi, Bronwyn
dc.contributor.authorJacobson, K.R.
dc.date.accessioned2021-10-22T00:05:49Z
dc.date.available2021-10-22T00:05:49Z
dc.date.issued2021
dc.identifier.citationRagan, E.J. and Gill, C.J. and Banos, M. and Bouton, T.C. and Rooney, J. and Horsburgh, C.R. and Warren, R.M. et al. 2021. Directly observed therapy to measure adherence to tuberculosis medication in observational research: Protocol for a prospective cohort study. JMIR Research Protocols. 10 (6): Article No. e24510.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/86126
dc.identifier.doi10.2196/24510
dc.description.abstract

Background: A major challenge for prospective, clinical tuberculosis (TB) research is accurately defining a metric for measuring medication adherence. Objective: We aimed to design a method to capture directly observed therapy (DOT) via mobile health carried out by community workers. The program was created specifically to measure TB medication adherence for a prospective TB cohort in Western Cape Province, South Africa.

Methods: Community workers collect daily adherence data on mobile smartphones. Participant-level adherence, program-level adherence, and program function are systematically monitored to assess DOT program implementation. A data dashboard allows for regular visualization of indicators. Numerous design elements aim to prevent or limit data falsification and ensure study data integrity.

Results: The cohort study is ongoing and data collection is in progress. Enrollment began on May 16, 2017, and as of January 12, 2021, a total of 236 participants were enrolled. Adherence data will be used to analyze the study’s primary aims and to investigate adherence as a primary outcome.

Conclusions: The DOT program includes a mobile health application for data collection as well as a monitoring framework and dashboard. This approach has potential to be adapted for other settings to improve the capture of medication adherence in clinical TB research.

dc.languageeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectdirectly observed therapy
dc.subjectmedication adherence
dc.subjectmobile applications
dc.subjecttreatment adherence and compliance
dc.subjecttuberculosis
dc.titleDirectly observed therapy to measure adherence to tuberculosis medication in observational research: Protocol for a prospective cohort study
dc.typeJournal Article
dcterms.source.volume10
dcterms.source.number6
dcterms.source.startPagee24510
dcterms.source.issn1929-0748
dcterms.source.titleJMIR Research Protocols
dc.date.updated2021-10-22T00:05:49Z
curtin.departmentEnAble Institute
curtin.accessStatusOpen access
curtin.facultyFaculty of Health Sciences
curtin.contributor.orcidMyers-Franchi, Bronwyn [0000-0003-0235-6716]
dcterms.source.eissn1929-0748
curtin.contributor.scopusauthoridMyers-Franchi, Bronwyn [7202684194]


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/